An Appraisal on the Value of Using Nutraceutical Based Senolytics and Senostatics in Aging
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The average human life expectancy has increased globally, and continues to rise, owing to the substantive progress made in healthcare, medicine, sanitation, housing and education. This ultimately enriches society with a greater proportion of elderly people. Sustaining a healthy aged population is key to diminish the societal and economic impact of age-related infirmities. This is especially challenging because tissue function, and thus wellbeing, naturally progressively decline as humans age. With age increasing the risk of developing diseases, one of the therapeutic options is to interfere with the molecular and cellular pathways involved in age-related tissue dysfunction, which is in part caused by the accumulation of senescent cells. One strategy to prevent this could be using drugs that selectively kill these cells (senolytics). In parallel, some compounds have been identified that prevent or slow down the progression of senescence or some of its features (senostatics). Senolytic and senostatic therapies have been shown to be efficient in vivo, but they also have unwanted dose-dependent side effects, including toxicity. Important advances might be made using bioactive compounds from plants and foods (nutraceuticals) if, as is proposed, they offer similar effectiveness with fewer side effects. The focus of this review is on the use of nutraceuticals in interfering with cellular senescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 1×
“(2015), in whose work the combination of quercetin and dasatinib showed potential apoptotic activity in eliminating senescent cells (Zhu et al., 2015).”
BackgroundSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444
Hickson, L. J., Langhi Prata, L. G. P., Bobart, S. A., Evans, T. K., Giorgadze, N., Hashmi, S. K., Herrmann, S. M., Jensen, M. D., Jia, Q., Jordan, K. L., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.069 · Cited by 1,383
Rapamycin: one drug, many effects
Li, J., Kim, S. G., & Blenis, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.001 · Cited by 1,287
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261 · cited 1×
“This combination is now being tested as part of clinical trials to investigate its potential in patients with idiopathic pulmonary fibrosis, with preliminary results already showing improvements in cardiopulmonary function (Justice et al., 2019).”
BackgroundDirected elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
Fisetin is a senotherapeutic that extends health and lifespan
Yousefzadeh, M. J., Zhu, Y., McGowan, S. J., Angelini, L., Fuhrmann-Stroissnigg, H., Xu, M., Ling, Y. Y., Melos, K. I., Pirtskhalava, T., Inman, C. L., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.09.015 · Cited by 1,032
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
Hewitt, G., Jurk, D., Marques, F. D. M., Correia-Melo, C., Hardy, T., Gackowska, A., Anderson, R., Taschuk, M., Mann, J., & Passos, J. F. (2012) · Nature Communications · doi:10.1038/ncomms1708 · Cited by 908
Identification of HSP90 inhibitors as a novel class of senolytics
Fuhrmann-Stroissnigg, H., Ling, Y. Y., Zhao, J., McGowan, S. J., Zhu, Y., Brooks, R. W., Grassi, D., Gregg, S. Q., Stripay, J. L., Dorronsoro, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00314-z · Cited by 701
Moiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
Excessive Cell Growth Causes Cytoplasm Dilution And Contributes to Senescence
Neurohr, G. E., Terry, R. L., Lengefeld, J., Bonney, M., Brittingham, G. P., Moretto, F., Miettinen, T. P., Vaites, L. P., Soares, L. M., Paulo, J. A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.018 · Cited by 518
Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Baker, D. J., & Petersen, R. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95145 · Cited by 514
From Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence
Wiley, C. D., & Campisi, J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.010 · Cited by 440
Identification and characterization of Cardiac Glycosides as senolytic compounds
Triana-Martínez, F., Picallos-Rabina, P., Da Silva-Álvarez, S., Pietrocola, F., Llanos, S., Rodilla, V., Soprano, E., Pedrosa, P., Ferreirós, A., Barradas, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12888-x · Cited by 384
Cardiac glycosides are broad-spectrum senolytics
Guerrero, A., Herranz, N., Sun, B., Wagner, V., Gallage, S., Guiho, R., Wolter, K., Pombo, J., Irvine, E. E., Innes, A. J., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0122-z · Cited by 359
de Jesus, B. B., Schneeberger, K., Vera, E., Tejera, A., Harley, C. B., & Blasco, M. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00700.x · Cited by 348
Astle, M. V., Hannan, K. M., Ng, P. Y., Lee, R. S., George, A. J., Hsu, A. K., Haupt, Y., Hannan, R. D., & Pearson, R. B. (2012) · Oncogene · doi:10.1038/onc.2011.394 · Cited by 295
Cell cycle arrest is not senescence
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100281 · Cited by 217
Senescent cells: a therapeutic target for cardiovascular disease
Childs, B. G., Li, H., & van Deursen, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95146 · Cited by 192
Paracrine roles of cellular senescence in promoting tumourigenesis
Gonzalez-Meljem, J. M., Apps, J. R., Fraser, H. C., & Martinez-Barbera, J. P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0066-1 · Cited by 183
A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
Samaraweera, L., Adomako, A., Rodriguez-Gabin, A., & McDaid, H. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-01964-1 · Cited by 183
Stable Cellular Senescence Is Associated with Persistent DDR Activation
Fumagalli, M., Rossiello, F., Mondello, C., & d’Adda di Fagagna, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110969 · Cited by 183
Anti-senescence compounds: A potential nutraceutical approach to healthy aging
Gurău, F., Baldoni, S., Prattichizzo, F., Espinosa, E., Amenta, F., Procopio, A. D., Albertini, M. C., Bonafè, M., & Olivieri, F. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.001 · Cited by 179
Techniques to induce and quantify cellular senescence
Noren Hooten, N., & Evans, M. K. (2017) · Journal of Visualized Experiments · doi:10.3791/55533 · Cited by 178 · cited 1×
“These markers include, but are not limited to, senescence associated beta-galactosidase staining (SA-β-Gal), cell cycle arrest, morphological and nuclear changes, and expression of certain proteins (Hooten and Evans, 2017).”
Background“Social Life” of Senescent Cells: What Is SASP and Why Study It?
Borodkina, A. V., Deryabin, P. I., Giukova, А. А., & Nikolsky, N. N. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-4-14 · Cited by 170
Mouse models of ageing and their relevance to disease
Kõks, S., Dogan, S., Tuna, B. G., González-Navarro, H., Potter, P., & Vandenbroucke, R. E. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.10.001 · Cited by 125
Old cells, new tricks: chromatin structure in senescence
Parry, A. J., & Narita, M. (2016) · Mammalian Genome · doi:10.1007/s00335-016-9628-9 · Cited by 53
Research works printed but not linked: 63
- Aird, 2012, Detection of senescence-associated heterochromatin foci (SAHF)., Methods Mol. Biol., 965, 185, 10.1007/978-1-62703-239-1_12 · DOI · Paper page
- Althubiti, 2016, BTK modulates p53 activity to enhance apoptotic and senescent responses., Cancer Res., 76, 5405, 10.1158/0008-5472.CAN-16-0690 · DOI
- Bailey, 2017, Metformin: historical overview., Diabetologia, 60, 1566, 10.1007/s00125-017-4318-z · DOI · Paper page
- Bernadotte, 2016, Markers of cellular senescence. Telomere shortening as a marker of cellular senescence., Aging, 8, 3, 10.18632/aging.100871 · DOI · Paper page
- Boothman, 2008, Stress-induced premature senescence (SIPS) – influence of SIPS on radiotherapy., J. Radiat. Res., 49, 105, 10.1269/jrr.07081 · DOI
- Calado, 2013, Telomere dynamics in mice and humans., Semin. Hematol., 50, 165, 10.1053/j.seminhematol.2013.03.030 · DOI · Paper page
- Ciccarone, 2018, DNA methylation dynamics in aging: how far are we from understanding the mechanisms?, Mech. Age. Dev., 174, 3, 10.1016/j.mad.2017.12.002 · DOI · Paper page
- Demidenko, 2009, At concentrations that inhibit mTOR, resveratrol suresses cellular senescence., Cell Cycle, 8, 1901, 10.4161/cc.8.12.8810 · DOI
- Dimri, 1995, A biomarker that identifies senescent human cells in culture and in aging skin in vivo., Cell Biol., 92, 9363, 10.1073/pnas.92.20.9363 · DOI · Paper page
- Dimri, 2005, What has senescence got to do with cancer?, Cancer Cell, 7, 505, 10.1016/j.ccr.2005.05.025 · DOI · Paper page
- Freund, 2012, Lamin B1 loss is a senescence-associated biomarker., Mol. Biol. Cell, 23, 2066, 10.1091/mbc.E11-10-0884 · DOI · Paper page
- Fu, 2016, Effects of senescent lens epithelial cells on the severity of age-related cortical cataract in humans., Medicine, 95, 10.1097/MD.0000000000003869 · DOI
- Garbers, 2013, Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR)., Cell Cycle, 12, 3421, 10.4161/cc.26431 · DOI · Paper page
- Giaimo, 2012, Is cellular senescence an example of antagonistic pleiotropy?, Aging Cell, 11, 378, 10.1111/j.1474-9726.2012.00807.x · DOI
- Gilbert, 2000, Developmental biology, Aging: The Biology of Senescence
- Giovannelli, 2012, Beneficial effects of olive oil phenols on the aging process: experimental evidence and possible mechanisms of action., Nutr. Aging, 1, 207, 10.3233/nua-130016 · DOI
- González-Hunt, 2018, DNA damage by oxidative stress: measurement strategies for two genomes., Curr. Opin. Toxicol., 7, 87, 10.1016/j.cotox.2017.11.001 · DOI
- Han, 2012, Preventative effects of Epigallocatechin-3-O-Gallate against replicative senescence associated with p53 acetylation in human dermal fibroblasts., Oxid. Med. Cell. Longev., 2012, 10.1155/2012/850684 · DOI
- Hayflick, 1961, The serial cultivation of human diploid cell strains., Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
- Hernández-Segura, 2018, Hallmarks of cellular senescence., Trends Cell Biol., 28, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
- Huang, 2014, Senescence-associated β-galactosidase activity marks the visceral endoderm of mouse embryos but is not indicative of senescence., Genesis, 52, 300, 10.1002/dvg.22761 · DOI
- Jackson, 2009, The DNA-damage response in human biology and disease., Nature, 461, 1071, 10.1038/nature08467 · DOI · Paper page
- Jeon, 2018, Senescent cells and osteoarthritis: a painful connection., J. Clin. Investig., 128, 1229, 10.1172/JCI95147 · DOI · Paper page
- Jeon, 2018, Anti-inflammatory and anti-aging effects of hydroxytyrosol on human dermal fibroblasts (HDFs)., Biomed. Dermatol., 2, 10.1186/s41702-018-0031-x · DOI
- Jingwen, 2017, Cell cycle regulation and anticancer drug discovery., Cancer Biol. Med., 14, 348, 10.20892/j.issn.2095-3941.2017.0033 · DOI · Paper page
- Katsiki, 2007, The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts., Rejuvenat. Res., 10, 157, 10.1089/rej.2006.0513 · DOI · Paper page
- Khan, 2016, Generating primary fibroblast cultures from mouse ear and tail tissues., J. Vis. Exp., 107, 10.3791/53565 · DOI
- Khan, 2013, Fisetin: a dietary antioxidant for health promotion., Antioxid. Redox Signal., 19, 151, 10.1089/ars.2012.4901 · DOI · Paper page
- Kim, 2018, Skin protective effect of epigallocatechin gallate., Int. J. Mol. Sci., 19, 10.3390/ijms19010173 · DOI · Paper page
- Ko, 2018, Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF., Cell Death Diff., 25, 1050, 10.1038/s41418-018-0072-0 · DOI
- Kumar, 2018, Epigallocatechin gallate suresses premature senescence of preadipocytes by inhibition of PI3K/Akt/mTOR pathway and induces senescent cell death by regulation of Bax/Bcl-2 pathway., Biogerontology, 20, 171, 10.1007/s10522-018-9785-1 · DOI
- Malavolta, 2018, Inducers of senescence, toxic compounds, and senolytics: the multiple faces of Nrf2-activating phytochemicals in cancer adjuvant therapy., Mediators Inflamm., 2018, 1, 10.1155/2018/4159013 · DOI
- Marković, 2019, Hydroxytyrosol, tyrosol and derivatives and their potential effects on human health., Molecules, 24, 10.3390/molecules24102001 · DOI · Paper page
- Menicacci, 2017, Modulation of the senescence-associated inflammatory phenotype in human fibroblasts by olive phenols., Int. J. Mol. Sci., 18, 10.3390/ijms18112275 · DOI · Paper page
- Miller, 2010, Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice., J. Gerontol. Ser. A, 191, 10.1093/gerona/glq178 · DOI · Paper page
- PubChem Database(-)-Epigallocatechin gallate, CID=65064.
- PubChem Database Fisetin, CID=5281614.
- PubChem Database Hydroxytyrosol, CID=82755.
- PubChem Database Oleuropein aglycone, CID=56842347.
- PubChem Database Resveratrol, CID=445154.
- Niu, 2013, The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age-associated inflammation and oxidative stress in healthy rats., Aging Cell, 12, 1041, 10.1111/acel.12133 · DOI · Paper page
- Paez-Ribes, 2019, Targeting senescent cells in translational medicine., EMBO Mol. Med., 11, 10.15252/emmm.201810234 · DOI · Paper page
- Qian, 2012, Senescence regulation by the p53 protein family., Methods Mol. Biol., 965, 37, 10.1007/978-1-62703-239-1_3 · DOI · Paper page
- Rafieian-Kopaei, 2014, New concepts in nutraceuticals as an alternative for pharmaceuticals., Int. J. Prevent. Med., 5, 1487
- Risuleo, 2016, Resveratrol., Nutraceuticals, 5, 453, 10.1016/B978-0-12-802147-7.00033-4 · DOI
- Sáez, 2014, The mechanistic links between proteasome activity, aging and age-related diseases., Curr. Genomics, 15, 38, 10.2174/138920291501140306113344 · DOI · Paper page
- Salehi, 2018, Resveratrol: a double-edged sword in health benefits., Biomedicines, 6, 10.3390/biomedicines6030091 · DOI · Paper page
- Serrano, 2014, Cellular senescence: from physiology to pathology., Nat. Rev. Mol. Cell Biol., 15, 482, 10.1038/nrm3823 · DOI · Paper page
- Shammas, 2011, Telomeres, lifestyle, cancer, and aging., Curr. Opin. Clin. Nutr. Metab. Care, 14, 28, 10.1097/mco.0b013e32834121b1 · DOI · Paper page
- Short, 2019, Senolytics and senostatics as adjuvant tumour therapy., EBioMedicine, 41, 683, 10.1016/j.ebiom.2019.01.056 · DOI · Paper page
- Strong, 2012, Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice., J. Gerontol. Ser. A Biol. Sci. Med. Sci., 68, 6, 10.1093/gerona/gls070 · DOI · Paper page
- Sun, 2017, Oleuropein, unexpected benefits!, Oncotarget, 8
- Tabasso, 2019, Radiotherapy-induced senescence and its effects on responses to treatment., Clin. Oncol., 31, 283, 10.1016/j.clon.2019.02.003 · DOI
- Tsoukalas, 2019, Discovery of potent telomerase activators: unfolding new therapeutic, and anti-aging perspectives., Mol. Med. Rep., 20, 3701, 10.3892/mmr.2019.10614 · DOI
- Tuck, 2002, Major phenolic compounds in olive oil: metabolism and health effects., J. Nutr. Biochem., 13, 636, 10.1016/s0955-2863(02)00229-2 · DOI · Paper page
- Unno, 2016, Prevention of brain aging by green tea components: role of catechins and theanine., J. Phys. Fitness Sports Med., 5, 117, 10.7600/jpfsm.5.117 · DOI
- Unno, 2006, Daily consumption of green tea catechin delays memory regression in aged mice., Biogerontology, 8, 89, 10.1007/s10522-006-9036-8 · DOI
- van Deursen, 2014, The role of senescent cells in ageing., Nature, 509, 439, 10.1038/nature13193 · DOI · Paper page
- Wang, 2017, Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism., Aging Cell, 16, 564, 10.1111/acel.12587 · DOI · Paper page
- Xia, 2009, Resveratrol reduces endothelial progenitor cells senescence through augmentation of telomerase activity by Akt-dependent mechanisms., Br. J. Pharmacol., 155, 387, 10.1038/bjp.2008.272 · DOI
- Yao, 2014, Modelling mammalian cellular quiescence., Interface Focus, 4, 10.1098/rsfs.2013.0074 · DOI · Paper page
- Yousefzadeh, Mouse models of accelerated cellular senescence., Methods Mol. Biol., 1896, 203, 10.1007/978-1-4939-8931-7_17 · DOI
- Zhang, 2016, Human specific regulation of the telomerase reverse transcriptase gene., Genes, 7, 10.3390/genes7070030 · DOI
Cited by
Identification and characterization of Cardiac Glycosides as senolytic compounds
Triana-Martínez, F., Picallos-Rabina, P., Da Silva-Álvarez, S., Pietrocola, F., Llanos, S., Rodilla, V., Soprano, E., Pedrosa, P., Ferreirós, A., Barradas, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12888-x · Cited by 384
Boyajian, J. L., Ghebretatios, M., Schaly, S., Islam, P., & Prakash, S. (2021) · Nutrients · doi:10.3390/nu13124550 · Cited by 115
A Blueprint for Characterizing Senescence
Roy, A. L., Sierra, F., Howcroft, K., Singer, D. S., Sharpless, N., Hodes, R. J., Wilder, E. L., & Anderson, J. M. (2020) · Cell · doi:10.1016/j.cell.2020.10.032 · Cited by 81
Sumsuzzman, D. M., Khan, Z. A., Choi, J., & Hong, Y. (2021) · Aging · doi:10.18632/aging.202894 · Cited by 19
Metadata
- Authors
- Kaur, A., Macip, S., & Stover, C. M.
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-03
- Volume
- 8
- Pages
- 218-218
- ISSN
- 2296-634X (ISSN-L)
- OpenAlex
- W3014546834
- Cited by
- 26
- References
- 32
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Biotechnology and Biological Sciences Research Council
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.